hmmm not much news on the lens trial. wonder how it's going? not too well i'd imagine from the delay.
Not much time left on BOSOA. Can't see the share price increasing too much either with millions of options on the market ex at 0.20. It could be that if people were aiming to cover the ex price with subsequent share selling they will exercise and then sell shares for the slightest margin.
Actually, thinking about it, if you had the money now, you'd be better off just buying shares than exercising options.
BOS has good prospects, but it looks like most of the action will be next year.
BOS Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
